Published in Blood Weekly, January 3rd, 2008
"Mean TNC and CD34+ viable cells recoveries were 55.97 +/- 18.6 and 98.0 +/- 36.5%, respectively. Mean cell viability was 68.25 +/- 18.9%. TNC recovery was correlated with viability but independent of the initial nucleated cell concentration. No difference in TNC recovery or viability was observed according to underlying diseases, except for myeloma, for which these...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.